CYTOSOLIC FREE CALCIUM CONCENTRATIONS IN LYMPHOCYTES FROM MALIGNANT HYPERTHERMIA SUSCEPTIBLE PATIENTS

被引：5
|
作者：
ORDING, H
FODER, B
SCHARFF, O
机构：
[1] HERLEV HOSP,DEPT ANAESTHESIA,DK-2730 HERLEV,DENMARK
[2] RIGSHOSP,DEPT ANAESTHESIA,DK-2730 HERLEV,DENMARK
[3] RIGSHOSP,DEPT CLIN PHYSIOL & NUCL MED,DK-2100 COPENHAGEN O,DENMARK
来源：
BRITISH JOURNAL OF ANAESTHESIA | 1990年 / 64卷 / 03期
关键词：
Anaesthetics volatile: halothane; Hyperthermia:; malignant; lymphocytes; Lons:; calcium; intracellular;
D O I：
10.1093/bja/64.3.341
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
Halothane in concentrations exceeding 1.2 mmol litre-1 increased (P < 0.05) the apparent intracellular concentration of calcium in lymphocytes from 12 patients being tested for susceptibility to malignant hyperthermia (MH) using the fluorescent Ca2+ indicator, fura2. There was no difference in [Ca2+], between lymphocytes from patients found to be MH susceptible (n = 5) on in vitro contracture testing with halothane and caffeine and those from MH negative patients (n = 6). Thus determination of [Ca2+], in lymphocytes after exposure to halothane could not be used as a diagnostic test for MH susceptibility. © 1990 British Journal of Anaesthesia.
引用
收藏
页码：341 / 345
页数：5
相关论文
共 50 条
  • [41] INCREASE IN CYTOPLASMIC FREE CA2+ CAUSED BY HALOTHANE IN LYMPHOCYTES FROM MALIGNANT HYPERTHERMIA PATIENTS AND PIGS
    KLIP, A
    BRITT, BA
    ELLIOTT, ME
    JOURNAL OF GENERAL PHYSIOLOGY, 1986, 88 (06): : A33 - A33
  • [42] PROPOFOL IS A SAFE ANESTHETIC AGENT IN MALIGNANT HYPERTHERMIA SUSCEPTIBLE PATIENTS
    MCKENZIE, AJ
    COUCHMAN, KG
    POLLOCK, N
    ANAESTHESIA AND INTENSIVE CARE, 1992, 20 (02) : 165 - 168
  • [43] Using Informatics to Improve the Care of Patients Susceptible to Malignant Hyperthermia
    Denholm, Bonnie G.
    AORN JOURNAL, 2016, 103 (04) : 364 - 376
  • [44] B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators
    Girard, T
    Cavagna, D
    Padovan, E
    Spagnoli, G
    Urwyler, A
    Zorzato, F
    Treves, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (51) : 48077 - 48082
  • [45] MANAGEMENT OF OTOLARYNGIC PATIENTS SUSCEPTIBLE TO MALIGNANT HYPERTHERMIA WITHOUT DANTROLENE
    DERKAY, CS
    GRUNDFAST, KM
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1991, 105 (05) : 680 - 686
  • [46] Management of patients susceptible to malignant hyperthermia: A surgeon?s perspective
    Carlson, Kevin J.
    Sun, Sara A.
    Swan, Carol
    Koenig, Matthias
    Derkay, Craig S.
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2022, 159
  • [47] In-vitro effects of cocaine in malignant hyperthermia susceptible patients
    Weisshorn, R
    Wappler, F
    Scholz, J
    Fiege, M
    Esch, JSA
    ANESTHESIOLOGY, 1999, 91 (3A) : U216 - U216
  • [48] Safe duration of postoperative monitoring for malignant hyperthermia susceptible patients
    Pollock, N
    Langton, E
    Stowell, K
    Simpson, C
    McDonnell, N
    ANAESTHESIA AND INTENSIVE CARE, 2004, 32 (04) : 502 - 509
  • [49] Altered voltage dependence of calcium release in myotubes of malignant hyperthermia susceptible pigs
    Dietze, B
    Eichinger, HM
    Erhardt, W
    Melzer, W
    BIOPHYSICAL JOURNAL, 1997, 72 (02) : WP141 - WP141
  • [50] EFFECT OF HALOTHANE ON PLATELETS NUCLEOTIDE LEVELS FROM NON-SUSCEPTIBLE AND MALIGNANT HYPERTHERMIA-SUSCEPTIBLE PATIENTS
    GIGER, U
    KAPLAN, RF
    CLINICAL RESEARCH, 1982, 30 (02): : A252 - A252
12345